Molecular profiling in diffuse large B-cell lymphoma: why so many types of subtypes?

Area of Science:

• Hematology
• Oncology
• Genetics

Background:

• Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous malignancy.
• Tumor heterogeneity impedes targeted therapy development.
• Existing classification systems do not fully capture DLBCL's biological diversity.

Purpose of the Study:

• To review molecular profiling studies proposing new DLBCL classifications.
• To focus on studies identifying novel genetic subgroups.
• To discuss implications for clinical practice and trials.

Main Methods:

• Review of major molecular profiling studies.
• Analysis of proposed genetic subgroups of DLBCL.
• Synthesis of consensus and discordance among studies.

Main Results:

• Molecular profiling reveals distinct DLBCL subgroups.
• These subgroups are often defined by shared oncogenic pathways.
• Proposed classifications may bridge existing lymphoma categories.

Conclusions:

• New molecular classifications offer potential to manage DLBCL heterogeneity.
• Genomic subtyping is crucial for precision medicine in DLBCL.
• Addressing challenges in genomic subtyping will advance DLBCL treatment.